Disulfiram
| Status | Commercial |
| Development phase | |
| Therapeutic cat. | Other |
| Polymorphic form | Substance does not show polymorphism |
| CAS No. | 97-77-8 |
| Reference Product | |
| Injectable Form | |
| EU DMF readiness |  |
| CEP | |
| CHINESE DMF | |
| JAPANESE DMF | |
| KOREAN DMF | |
| CANADIAN DMF | |
| CADIFA | |
| US DMF readiness | |
| OEB No. | |
| Samples |
Drug description
Disulfiram may be used to treat alcohol use disorder (also called chronic alcoholism) and works by blocking an enzyme that is involved in breaking down alcohol. Combining disulfiram with alcohol produces very unpleasant side effects which can help keep you from drinking. Disulfiram is not a cure for alcohol use disorder and other non-drug treatments, such as behavior modification, psychotherapy, and counseling support are needed in addition to disulfiram to give you the best possible chance to stop drinking. Disulfiram was FDA approved in 1951.
Polpharma API
- No risk of nitrosoamine presence
- All intermediates produced in-house
Disclaimer
Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).
